 Acquisition Advances Companys Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis Acquisition Advances Companys Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis 